Replicating oncolytic virus therapeutics - Third International Meeting.
Bell
John
J
Ottawa Regional Cancer Centre, Ontario, Canada. jbell@ohri.ca
D000256:Adenoviridae / Q000502:physiology; D000818:Animals; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000473:pathology / Q000628:therapy / Q000821:virology; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009522:Newcastle disease virus / Q000276:immunology / Q000502:physiology*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D014765:Viral Vaccines / Q000008:administration & dosage / Q000627:therapeutic use; D014779:Virus Replication / Q000502:physiology*
D007166:Immunosuppressive Agents; C424862:Newcastle disease virus vaccine MTH-68-H; D014765:Viral Vaccines; D000068338:Everolimus; D020123:Sirolimus